News

Results indicate Black patients are 25% less likely to receive stroke-preventing medication.

Sub-analysis indicates patients with intermittent monitoring may not be optimally managed for secondary stroke prevention

Presentations include data highlighting the role of diagnostic and therapeutic catheters, mapping software and digital technologies in advancing cardiac arrhythmia treatment, and real-world evidence informing treatment pathways and patient...

Non-invasive arrhythmia technology maps using only the data from a 12 lead ECG. vMap provides actionable mapping results in minutes.

Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial fibrillation experiencing an improved quality of life.

First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke 

AtaCor Medical, Inc announced that it will present initial findings from its first-in-human extravascular implantable cardioverter defibrillator (EV-ICD) study during the upcoming Stanford Biodesign New Arrhythmia Technologies Retreat.

University of Vermont Medical Center Initiates Evaluation of the ECGenius System as CathVision Prepares for U.S. Launch.

Following a year of significant growth, specialty reprocessor invests heavily in extending the applications of reprocessing to help hospitals meet their financial and environmental goals.

VitalStream™, Featuring Patented Pulse Decomposition Analysis™ technology becomes the World’s First Wireless Wearable Monitor for Continuous Blood Pressure and Advanced Hemodynamics – All with a single, easy-to-apply Finger Sensor